Company Filing History:
3 out of 7 
2 out of 2 
2 out of 415 
Years Active: 2001-2014
Title: Hyman M Schipper: Innovator in Cancer Treatment
Introduction
Hyman M Schipper is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 5 patents, Schipper's work focuses on developing compositions and methods that enhance the efficacy of cancer therapies.
Latest Patents
One of Schipper's latest patents is titled "Compositions and methods for cancer treatment." This invention relates to compositions that comprise a vitamin E analog and an arsenic compound, aimed at treating hyperproliferative cell disorders such as cancer. The composition enhances arsenic toxicity towards cancer cells while preventing arsenic-mediated toxicity in non-cancerous cells. Another significant patent is for "Substituted imidazole derivatives and methods of use thereof for treating cancer." This patent discloses compounds that can be used alone or in combination with other chemotherapeutic agents to treat or prevent cancer and inhibit tumor tissue growth. These compounds also serve as neuroprotectants and can be beneficial in treating neurodegenerative disorders and other diseases of the central nervous system.
Career Highlights
Throughout his career, Hyman M Schipper has worked at the Sir Mortimer B. Davis Jewish General Hospital, where he has contributed to various research initiatives. His work has been instrumental in advancing cancer treatment methodologies and improving patient outcomes.
Collaborations
Schipper has collaborated with notable colleagues such as Ajay Gupta and Moulay Alaoui-Jamali. These partnerships have fostered a collaborative environment that enhances the research and development of innovative cancer treatments.
Conclusion
Hyman M Schipper's contributions to cancer treatment through his patented inventions highlight his dedication to improving healthcare. His innovative approaches continue to pave the way for advancements in the field of oncology.